{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:49:58Z","timestamp":1793713798203,"version":"4.6.1"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Metabolomics technology facilitates studying associations between small molecules and disease processes. Correlating metabolites in cerebrospinal fluid (CSF) with Alzheimer\u2019s disease (AD) CSF biomarkers may elucidate additional changes that are associated with early AD pathology and enhance our knowledge of the disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The relative abundance of untargeted metabolites was assessed in 161 individuals from the Wisconsin Registry for Alzheimer\u2019s Prevention. A metabolome-wide association study (MWAS) was conducted between 269 CSF metabolites and protein biomarkers reflecting brain amyloidosis, tau pathology, neuronal and synaptic degeneration, and astrocyte or microglial activation and neuroinflammation. Linear mixed-effects regression analyses were performed with random intercepts for sample relatedness and repeated measurements and fixed effects for age, sex, and years of education. The metabolome-wide significance was determined by a false discovery rate threshold of 0.05. The significant metabolites were replicated in 154 independent individuals from then Wisconsin Alzheimer\u2019s Disease Research Center. Mendelian randomization was performed using genome-wide significant single nucleotide polymorphisms from a CSF metabolites genome-wide association study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Metabolome-wide association study results showed several significantly associated metabolites for all the biomarkers except A\u03b242\/40 and IL-6. Genetic variants associated with metabolites and Mendelian randomization analysis provided evidence for a causal association of metabolites for soluble triggering receptor expressed on myeloid cells 2 (sTREM2), amyloid \u03b2 (A\u03b240), \u03b1-synuclein, total tau, phosphorylated tau, and neurogranin, for example, palmitoyl sphingomyelin (d18:1\/16:0) for sTREM2, and erythritol for A\u03b240 and \u03b1-synuclein.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This study provides evidence that CSF metabolites are associated with AD-related pathology, and many of these associations may be causal.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnagi.2023.1214932","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T06:25:03Z","timestamp":1693463103000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["CSF metabolites associated with biomarkers of Alzheimer\u2019s disease pathology"],"prefix":"10.3389","volume":"15","author":[{"given":"Ruocheng","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongshi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunseung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivonne","family":"Suridjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendlyn","family":"Kollmorgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuetiva","family":"Deming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Van Hulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozalyn M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia M.","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Asthana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterling C.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne D.","family":"Engelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,30]]},"reference":[{"key":"B1","year":"2019","journal-title":"Fluid AD biomarkers link P-Tau to synapses, inflammation."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4061\/2010\/606802","article-title":"CSF biomarkers for Alzheimer\u2019s disease diagnosis.","volume":"2010","author":"Anoop","year":"2010","journal-title":"Int. J. Alzheimers Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ajhg.2008.10.008","article-title":"Genome-wide association analysis reveals putative Alzheimer\u2019s disease susceptibility loci in addition to APOE.","volume":"83","author":"Bertram","year":"2008","journal-title":"Am. J. Hum. Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3233\/JAD-170602","article-title":"Cerebrospinal fluid and plasma levels of inflammation differentially relate to CNS markers of Alzheimer\u2019s disease pathology and neuronal damage.","volume":"62","author":"Bettcher","year":"2018","journal-title":"J. Alzheimers Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006221","article-title":"Fluid biomarkers in alzheimer disease.","volume":"2","author":"Blennow","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nn.3435","article-title":"CD33 Alzheimer\u2019s disease locus: Altered monocyte function and amyloid biology.","volume":"16","author":"Bradshaw","year":"2013","journal-title":"Nat. Neurosci"},{"key":"B7","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/j.1468-0262.2005.00632.x","article-title":"Consistent estimation with a large number of weak instruments.","volume":"73","author":"Chao","year":"2005","journal-title":"Econometrica"},{"key":"B8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3233\/JAD-160195","article-title":"Pathway-specific polygenic risk scores as predictors of \u03b2-amyloid deposition and cognitive function in a sample at increased risk for Alzheimer\u2019s disease.","volume":"55","author":"Darst","year":"2017","journal-title":"J. Alzheimers Dis. JAD"},{"key":"B9","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/gepi.22211","article-title":"Integrated analysis of genomics, longitudinal metabolomics, and Alzheimer\u2019s risk factors among 1,111 cohort participants.","volume":"43","author":"Darst","year":"2019","journal-title":"Genet. Epidemiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.neurobiolaging.2022.04.009","article-title":"Principal components from untargeted cerebrospinal fluid metabolomics associated with Alzheimer\u2019s disease biomarkers.","volume":"117","author":"Dong","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"B11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1083\/jcb.200207113","article-title":"Amyloidogenic processing of the Alzheimer \u03b2-amyloid precursor protein depends on lipid rafts.","volume":"160","author":"Ehehalt","year":"2003","journal-title":"J. Cell Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.bbadis.2010.06.007","article-title":"Mitochondrial involvement and erythronic acid as a novel biomarker in transaldolase deficiency.","volume":"1802","author":"Engelke","year":"2010","journal-title":"Biochim. Biophys. Acta BBA Mol. Basis Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2153?0769.1000132","article-title":"High resolution mass spectrometry improves data quantity and quality as compared to unit mass resolution mass spectrometry in high-throughput profiling metabolomics","volume":"4","author":"Evans","year":"2014","journal-title":"Metabolomics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jprot.2014.01.014","article-title":"Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer\u2019s disease.","volume":"104","author":"Gonz\u00e1lez-Dom\u00ednguez","year":"2014","journal-title":"J. Proteomics"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081813","article-title":"Towards a better understanding of GABAergic remodeling in Alzheimer\u2019s disease.","volume":"18","author":"Govindpani","year":"2017","journal-title":"Int. J. Mol. Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","article-title":"Alzheimer\u2019s disease risk gene CD33 inhibits microglial uptake of amyloid beta.","volume":"78","author":"Griciuc","year":"2013","journal-title":"Neuron"},{"key":"B17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/01.wno.0000177307.21081.81","article-title":"Magnetic resonance spectroscopy.","volume":"25","author":"Gujar","year":"2005","journal-title":"J. Neuroophthalmol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease.","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1523\/JNEUROSCI.0861-04.2004","article-title":"A Seed for alzheimer amyloid in the brain.","volume":"24","author":"Hayashi","year":"2004","journal-title":"J. Neurosci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3233\/JAD-2007-11210","article-title":"Could carnosine or related structures suppress Alzheimer\u2019s disease?","volume":"11","author":"Hipkiss","year":"2007","journal-title":"J. Alzheimers Dis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease.","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat. Genet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/alz.12204","article-title":"An examination of a novel multipanel of CSF biomarkers in the Alzheimer\u2019s disease clinical and pathological continuum.","volume":"17","author":"Hulle","year":"2021","journal-title":"Alzheimers Dement"},{"key":"B23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.03.015","article-title":"Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer\u2019s disease and relationship to amyloid-\u03b2 and tau.","volume":"80","author":"Jacobs","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"B24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.jchromb.2005.10.053","article-title":"A novel, quantitative assay for homocarnosine in cerebrospinal fluid using stable-isotope dilution liquid chromatography\u2013tandem mass spectrometry.","volume":"830","author":"Jansen","year":"2006","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s12035-013-8536-1","article-title":"CD33 in Alzheimer\u2019s disease.","volume":"49","author":"Jiang","year":"2014","journal-title":"Mol. Neurobiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41591-020-0815-6","article-title":"Large-scale proteomic analysis of Alzheimer\u2019s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.","volume":"26","author":"Johnson","year":"2020","journal-title":"Nat. Med"},{"key":"B27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.dadm.2017.11.007","article-title":"The wisconsin registry for Alzheimer\u2019s prevention: A review of findings and current directions.","volume":"10","author":"Johnson","year":"2018","journal-title":"Alzheimers Dement. Diagn. Assess. Dis. Monit"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1353\/obs.2021.0029","article-title":"Ivmodel: an R package for inference and sensitivity analysis of instrumental variables models with one endogenous variable","volume":"7","author":"Kang","year":"2021","journal-title":"Observ. Stud"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041505","article-title":"Lipids and Alzheimer\u2019s disease.","volume":"21","author":"Kao","year":"2020","journal-title":"Int. J. Mol. Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3233\/JAD-142319","article-title":"Sphingomyelin SM(d18:1\/18:0) is significantly enhanced in cerebrospinal fluid samples dichotomized by pathological amyloid-\u03b2 42, Tau, and Phospho-Tau-181 levels.","volume":"44","author":"Koal","year":"2015","journal-title":"J. Alzheimers Dis"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/ijms14011310","article-title":"Phospholipids and Alzheimer\u2019s disease: Alterations, mechanisms and potential biomarkers.","volume":"14","author":"Kosicek","year":"2013","journal-title":"Int. J. Mol. Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9484217","article-title":"Kynurenine pathway metabolites as biomarkers in Alzheimer\u2019s disease.","volume":"2022","author":"Liang","year":"2022","journal-title":"Dis. Markers"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/1468-0262.00438","article-title":"Conditional likelihood ratio test for structural models.","volume":"71","author":"Moreira","year":"2003","journal-title":"Econometrica"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/alz.052290","article-title":"CSF sphingomyelin metabolites in Alzheimer\u2019s disease, neurodegeneration, and neuroinflammation.","volume":"17","author":"Morrow","year":"2021","journal-title":"Alzheimers Dement."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-018-0119-x","article-title":"Comparative analysis of cerebrospinal fluid metabolites in Alzheimer\u2019s disease and idiopathic normal pressure hydrocephalus in a Japanese cohort.","volume":"6","author":"Nagata","year":"2018","journal-title":"Biomark. Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/ng.801","article-title":"Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease.","volume":"43","author":"Naj","year":"2011","journal-title":"Nat. Genet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1038\/tp.2011.55","article-title":"Metabolome in progression to Alzheimer\u2019s disease.","volume":"1","author":"Ore\u0161i\u010d","year":"2011","journal-title":"Transl. Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.3390\/nu7053891","article-title":"The Role of Gangliosides in Neurodevelopment.","volume":"7","author":"Palmano","year":"2015","journal-title":"Nutrients"},{"key":"B39","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: Narrowing the gap between raw spectra and functional insights.","volume":"49","author":"Pang","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-01583-z","article-title":"Cerebrospinal fluid metabolomics identifies 19 brain-related phenotype associations.","volume":"4","author":"Panyard","year":"2021","journal-title":"Commun. Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1093\/brain\/aww142","article-title":"Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife.","volume":"139","author":"Racine","year":"2016","journal-title":"Brain"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization.","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"B43","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1198\/073500102288618658","article-title":"Survey of weak instruments and weak identification in generalized method of moments.","volume":"20","author":"Stock","year":"2002","journal-title":"J. Bus. Econ. Stat"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-019-0551-7","article-title":"Systemic and central nervous system metabolic alterations in Alzheimer\u2019s disease.","volume":"11","author":"van der Velpen","year":"2019","journal-title":"Alzheimers Res. Ther"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002482","article-title":"Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.","volume":"15","author":"Varma","year":"2018","journal-title":"PLoS Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0451-2","article-title":"The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer\u2019s disease.","volume":"10","author":"Vogt","year":"2018","journal-title":"Alzheimers Res. Ther"},{"key":"B47","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jalz.2017.01.008","article-title":"Dysregulation of lipids in Alzheimer\u2019s disease and their role as potential biomarkers.","volume":"13","author":"Wong","year":"2017","journal-title":"Alzheimers Dement"},{"key":"B48","author":"Wooldridge","year":"2010","journal-title":"Econometric analysis of cross section and panel data"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.bbadis.2016.03.001","article-title":"Graded perturbations of metabolism in multiple regions of human brain in Alzheimer\u2019s disease: Snapshot of a pervasive metabolic disorder.","volume":"1862","author":"Xu","year":"2016","journal-title":"Biochim. Biophys. Acta BBA Mol. Basis Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/nm1095-1062","article-title":"GM1 ganglioside\u2013bound amyloid \u03b2\u2013protein (A\u03b2): A possible form of preamyloid in Alzheimer\u2019s disease.","volume":"1","author":"Yanagisawa","year":"1995","journal-title":"Nat. Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the elastic net.","volume":"67","author":"Zou","year":"2005","journal-title":"J. R. Stat. Soc. Ser. B Stat. Methodol"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1214932\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T06:25:06Z","timestamp":1693463106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1214932\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,30]]},"references-count":51,"alternative-id":["10.3389\/fnagi.2023.1214932"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2023.1214932","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,30]]},"article-number":"1214932"}}